Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells
…, S Wolbank, S Zeisberger, A Zisch, SC Strom - Stem …, 2008 - academic.oup.com
… Placenta as a Potent Niche Source for Hematopoietic Stem/Progenitor Cells: Insights from …
detected in 4 of 10 naturally born placenta tested (S. Hennerbichler, unpublished data). It may …
detected in 4 of 10 naturally born placenta tested (S. Hennerbichler, unpublished data). It may …
Hepatocyte transplantation for the treatment of human disease
SC Strom, JR Chowdhury, IJ Fox - Seminars in liver disease, 1999 - thieme-connect.com
… ~ll for bridging putients to whole organ tran.s~7lantatior? and,forproviding nzetubolic support
… Shortage of donor organs and the need,for inzmuno.supl,re.s.sion are two rizajor hurdles to …
… Shortage of donor organs and the need,for inzmuno.supl,re.s.sion are two rizajor hurdles to …
Human hepatocyte transplantation: worldwide results
RA Fisher, SC Strom - Transplantation, 2006 - journals.lww.com
… along with ultrastructural changes in the brain’s corpus striatum, were reversed with splenic
… A through C cirrhotic patients, using the recipient’s cirrhotic left lateral segment as the donor …
… A through C cirrhotic patients, using the recipient’s cirrhotic left lateral segment as the donor …
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
…, C Brimer, K Yasuda, R Venkataramanan, S Strom… - Nature …, 2001 - nature.com
Variation in the CYP3A enzymes, which act in drug metabolism, influences circulating steroid
levels and responses to half of all oxidatively metabolized drugs. CYP3A activity is the sum …
levels and responses to half of all oxidatively metabolized drugs. CYP3A activity is the sum …
[HTML][HTML] Long-term culture of genome-stable bipotent stem cells from adult human liver
…, EES Nieuwenhuis, R Hoekstra, S Strom… - Cell, 2015 - cell.com
Despite the enormous replication potential of the human liver, there are currently no culture
systems available that sustain hepatocyte replication and/or function in vitro. We have shown …
systems available that sustain hepatocyte replication and/or function in vitro. We have shown …
[HTML][HTML] Treatment of the Crigler–Najjar syndrome type I with hepatocyte transplantation
…, K Dorko, BV Sauter, SC Strom - … England Journal of …, 1998 - Mass Medical Soc
Crigler–Najjar syndrome type I is a recessively inherited disorder characterized by severe
unconjugated hyperbilirubinemia beginning at birth. The syndrome results from an absence of …
unconjugated hyperbilirubinemia beginning at birth. The syndrome results from an absence of …
[HTML][HTML] Circumstellar material associated with solar-type pre-main-sequence stars-A possible constraint on the timescale for planet building
KM Strom, SE Strom, S Edwards… - … Journal (ISSN 0004 …, 1989 - adsabs.harvard.edu
… This source lies - 45” S of~ Tau, and is probably the source ofthe outflow reported by Heyer,
… log L) in Johnson’s tables of standard-star colors to derive … contributes to the observed …
… log L) in Johnson’s tables of standard-star colors to derive … contributes to the observed …
[HTML][HTML] Mapping the genetic architecture of gene expression in human liver
…, AJ Lusis, RC Smith, FP Guengerich, SC Strom… - PLoS …, 2008 - journals.plos.org
Genetic variants that are associated with common human diseases do not lead directly to
disease, but instead act on intermediate, molecular phenotypes that in turn induce changes in …
disease, but instead act on intermediate, molecular phenotypes that in turn induce changes in …
Clinical exome sequencing for genetic identification of rare Mendelian disorders
H Lee, JL Deignan, N Dorrani, SP Strom, S Kantarci… - Jama, 2014 - jamanetwork.com
… , there are instances in which the clinician’s input at the genomic data board discussion is
… PGL is only performed upon patient’s or physician’s request. There was only 1 such request …
… PGL is only performed upon patient’s or physician’s request. There was only 1 such request …
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
…, B Gliniak, J Bussiere, CA Smith, SS Strom, S Kelley… - Nature medicine, 2001 - nature.com
Apo2L/TRAIL-inducedapoptosis3, 15, while Apo2L/TRAIL. 0 did not (Fig. 2c, top).
ViabilityassaysusingAlamarBlue, MTT, CrystalVioletandToludineBlue (datanot shown) confirmed …
ViabilityassaysusingAlamarBlue, MTT, CrystalVioletandToludineBlue (datanot shown) confirmed …